Sponsored Links

FDA Approves New Drug Treatment For Long-Term Pain Relief After Shingles Attacks PDF Print E-mail
Medical News - Dermatology
The Food and Drug Administration (FDA) has approved the approval of Qutenza (capsaicin) 8% patch, a medicated skin patch that relieves the pain of post-herpetic neuralgia (PHN), a serious complication that can occur after a bout with shingles. Shingles is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chickenpox - the varicella-zoster virus...

Read more: Dermatology News From Medical News Today